Rats with low brain angiotensinogen do not exhibit insulin resistance during early aging

Endocrine

Volumn 30, Issue 2, 2006, Pages 167-174

  Kasper, Sherry O ^a   Ferrario, Carlos M ^a   Ganten, Detlev ^b   Diz, Debra I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Aging; Brain; Insulin; Renin angiotensin system; Transgenics

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; GLUCOSE; INSULIN; LEPTIN;

AGE DISTRIBUTION; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STATISTICAL ANALYSIS; TRANSGENIC RAT;

EID: 33847364813     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:30:2:167     Document Type: Article

References (44)

1. ALLHAT Officers and Coordinators for ALLHAT Collaborative Research Group. (2002). JAMA 288, 2981-2997.
2. Dahlof, B., Devereux, R., Kjeldsen, S., et al. (2002). Lancet 359, 995-1003.
3. Henriksen, E. J., Jacob, S., Kinnick, T. R., Teachey, M. K., and Krekler, M. (2001). Hypertension 38, 884-890.
4. Gilliam-Davis, S., Payne, V. S., Kasper, S. O., Robbins, M. E., and Diz, D. I. (2005). Hypertension 46, 818.
5. Julius, S., Kjeldsen, S. E., Weber, M., et al. (2004). Lancet 363, 2022-2031.
6. Folli, F., Saad, M. J., Velloso, L., et al. (1999). Exp. Clin. Endocrinol. Diabetes 107, 133-139.
7. Nakata, T., Takeda, K., Hatta, T., et al. (1998). J. Cardiovasc. Pharmacol. 31, 248-252.
8. Averill, D. B. and Diz, D. I. (2001). Brain Res. Bull. 51, 119-128.
9. Diz, D. I. and Averill, D. B. (2004). In: Primer on the autonomic nervous system. Robertson, D., Biaggioni, I., Burnstock, G., and Law, P. A. (eds.). Elsevier Academic Press: San Diego, CA.
10. Diz, D. I., Jessup, J. A., Westwood, B. M., et al. (2001). Clin. Exper. Pharmacol. Physiol. 29, 473-482.
11. Ellacott, K. L. and Cone, R. D. (2004). Recent Prog. Horm. Res. 59, 395-408.
12. Figlewicz, D. P. (2003). Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R882-R892.
13. Giza, B. K., Scott, T. R., and Vanderweele, D. A. (1992). Brain Res. Bull. 28, 637-639.
14. Kinnick, T. R., Youngblood, E. B., O'Keefe, M. P., Saengsirisuwan, V., Teachey, M. K., and Henriksen, E. J. (2002). J. Appl. Physiol. 93, 805-812.
15. Blendea, M. C., Jacobs, D., Stump, C. S., et al. (2005). Am. J. Physiol. Endocrinol. Metab. 288, E353-E359.
16. Kasper, S. O., Carter, C. S., Ferrario, C. M., et al. (2005). Physiol. Genomics 23, 311-317.
17. Moriguchi, A., Brosnihan, K. B., Kumagai, H., Ganten, D., and Ferrario, C. M. (1994). Am. J. Physiol. 266, R1273-R1279.
18. Senanayake, P. D., Moriguchi, A., Kumagai, H., Ganten, D., Ferrario, C. M., and Brosnihan, K. B. (1994). Peptides 15, 919-926.
19. Schinke, M., Bohm, M., Bricca, G., Lippoldt, A., Bader, M., and Ganten, D. (1995). Hypertension 26, 547.
20. Schinke, M., Baltatu, O., Bohm, M., et al. (1999). Proc. Natl. Acad. Sci. USA 96, 3975-3980.
21. Wang, H., Huang, B. S., Ganten, D., and Leenen, F. H. (2004). Circ. Res. 94, 843-849.
22. Huang, B. S., Ganten, D., and Leenen, F. H. (2001). Hypertension 37, 683-686.
23. Oden, S. D., Ganten, D., Ferrario, C. M., Chappell, M. C., and Diz, D. I. (2004). FASEB J. 18, A738..
24. Anderson, S. (1997). Nephrol. Dial. Transplant. 12, 1093-1094.
25. Chen, H., Sullivan, G., Yue, L. Q., Katz, A., and Quon, M. J. (2003). Am. J. Physiol. Endocrinol. Metab. 284, E804-E812.
26. Shiuchi, T., Iwai, M., Li, H. S., et al. (2004). Hypertension 43, 1003-1010.
27. Henriksen, E. J. and Jacob, S. (2003). J. Cell Physiol. 196, 171-179.
28. Tokita, Y., Franco-Saenz, R., Mulrow, P. J., and Ganten, D. (1994). Endocrinology 134, 253-257.
29. Mitchell, K. D., Jacinto, S. M., and Mullins, J. J. (1997). Am. J. Physiol. 273, F246-F253.
30. Bachmann, S., Peters, J., Engler, E., Ganten, D., and Mullins, J. (1992). Kidney Int. 41, 24-36.
31. Holness, M. J. and Sugden, M. C. (1998). J. Hypertens. 16, 369-376.
32. DeFronzo, R. A. (2004). Diabetes Care 4, 493-501.
33. Rocchini, A. P., Yang, J. Q., and Gokee, A. (2004). Hypertension 43, 1011-1016.
34. Hausman, D. B., DiGirolamo, M., Bartness, T. J., Hausman, G. J., and Martin, R. J. (2001). Obes. Rev. 2, 239-254.
35. Bader, M., Peters, J., Baltatu, O., Muller, D. N., Luft, F. C., and Ganten, D. (2001). J. Mol. Med. 79, 76-102.
36. Morimoto, S., Cassell, M. D., and Sigmund, C. D. (2002). J. Biol. Chem. 277, 33235-33241.
37. Sakai, K., Chapleau, M. W., Morimoto, S., Cassell, M. D., and Sigmund, C. D. (2004). Physiol. Genomics 20, 66-72.
38. Sherrod, M., Davis, D. R., Zhou, X., Cassell, M. D., and Sigmund, C. D. (2005). Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R1763-R1769.
39. Masuzaki, H., Paterson, J., Shinyama, H., et al. (2001). Science 294, 2166-2170.
40. Djavidani, B., Sander, M., Kreutz, R., et al. (1995). J. Hypertens. 13, 637-645.
41. Haynes, W. G., Sivitz, W. I., Morgan, D. A., Walsh, S. A., and Mark, A. L. (1997). Hypertension 30, 619-623.
42. Gonzalez, B. L., Kurnjek, M. L., Muller, A., and Basso, N. (2000). Am. J. Hypertens. 13, 1301-1307.
43. Kasper, S. O., Basso, N., Kurnjek, M. L., et al. (2005). Am. J. Nephrol. 25, 335-341.
44. Massiera, F., Seydoux, J., Geloen, A., et al. (2001). Endocrinology 142, 5220-5225.